Referred to the House Committee on Energy and Commerce.
This resolution expresses the House's support for designating March as Multiple System Atrophy Awareness Month and endorses funding for research. It is a non-binding statement by the House and does not create new law, change federal programs, or appropriate money. The resolution is meant to raise public awareness and encourage research and attention to the disorder, but it does not require federal agencies to take action or provide funding.
This is a simple resolution introduced in the House and referred to committee; it would only be voted on by the House and would not be sent to the President. Simple resolutions are non-binding and only require a majority in the chamber that considers them.
This non-binding House resolution expresses support for designating March as "Multiple System Atrophy Awareness Month," describes the disorder and its impacts, and endorses public awareness and funding for research into Multiple System Atrophy (MSA).
The resolution cites prevalence estimates, clinical symptoms, diagnostic challenges, lack of cure, and ongoing research efforts.
As a simple House resolution it's easily adoptable in the House but does not create law; becoming binding federal law is unlikely.
Relative to its intended legislative type, this bill functions as a straightforward commemorative resolution: it clearly defines the condition and purpose (raising awareness), and it states the symbolic designation. It does not provide implementation details, funding mechanisms, statutory amendments, or oversight provisions, which is consistent with the typical form and scope of a House resolution of this nature.
Libs want concrete, budgeted research funding; conservatives warn against implied federal spending.
These are examples from the analysis, not a ranked list of the most-affected groups.
Libs want concrete, budgeted research funding; conservatives warn against implied federal spending.
Likely welcomes the resolution as a low-cost way to raise awareness and push for research funding for a neglected neurodegenerative disease.
Sees it as aligned with priorities for patient advocacy, research investment, and health equity, though would prefer clearer funding commitments.
Generally supportive because it is non‑controversial and promotes research and awareness for a serious condition.
Wants clarity that the resolution is symbolic and oversight of any new spending or research priorities.
Likely views the resolution as well‑intentioned but largely symbolic; supportive of awareness but cautious about any implied increase in federal spending.
May push for private-sector or state-led research solutions instead.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a simple House resolution it's easily adoptable in the House but does not create law; becoming binding federal law is unlikely.
The bill has not accumulated any surfaced votes yet.
Libs want concrete, budgeted research funding; conservatives warn against implied federal spending.
As a simple House resolution it's easily adoptable in the House but does not create law; becoming binding federal law is unlikely.
Relative to its intended legislative type, this bill functions as a straightforward commemorative resolution: it clearly defines the condition and purpose (raising awareness), and it states the symbolic designation. It…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.